Sonoco Products Co.’s (SON - Free Report) unit Sonoco ThermoSafe has acquired London-based Laminar Medica from Clinimed (Holdings) Limited. Laminar Medica specializes in the design and manufacture of temperature controlled packaging for the global healthcare industry. Along with expanding Sonoco ThermoSafe’s global presence overall, the acquisition will particularly expand its footprint in the European Temperature-Controlled packaging market.
Operating since 1975, Laminar Medica provides solutions for products that necessitate refrigeration, ambient and frozen temperature control for shipments with duration ranging from 24 hours to 120 hours. Its insulated parcel and pallet shipping solutions are sold globally under well-known brands, including ChillTherm, FreezeTherm, ClimiTherm, MediPhase, MediPorter, MediSorb, and newly launched ChillTech and AmbiTech product lines.
Sonoco ThermoSafe in its own right is a leading global provider of temperature assurance packaging to ensure safe transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. With operations spread over North America, South America, Europe and Asia, it has a massive product offering featuring industry-leading technology that includes refrigerated, frozen or controlled room temperature applications.
SONOCO PRODUCTS Price
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Sonoco Products Co.’s (SON - Free Report) unit Sonoco ThermoSafe has acquired London-based Laminar Medica from Clinimed (Holdings) Limited. Laminar Medica specializes in the design and manufacture of temperature controlled packaging for the global healthcare industry. Along with expanding Sonoco ThermoSafe’s global presence overall, the acquisition will particularly expand its footprint in the European Temperature-Controlled packaging market.
Operating since 1975, Laminar Medica provides solutions for products that necessitate refrigeration, ambient and frozen temperature control for shipments with duration ranging from 24 hours to 120 hours. Its insulated parcel and pallet shipping solutions are sold globally under well-known brands, including ChillTherm, FreezeTherm, ClimiTherm, MediPhase, MediPorter, MediSorb, and newly launched ChillTech and AmbiTech product lines.
Sonoco ThermoSafe in its own right is a leading global provider of temperature assurance packaging to ensure safe transport of pharmaceuticals, biologics, vaccines and other temperature-sensitive products. With operations spread over North America, South America, Europe and Asia, it has a massive product offering featuring industry-leading technology that includes refrigerated, frozen or controlled room temperature applications.
SONOCO PRODUCTS Price
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SON - FREE
Get the latest research report on PKG - FREE
Get the latest research report on BERY - FREE
Get the latest research report on UFPT - FREE